Opportunity Information: Apply for CDC RFA PS09 9020301SUPP11
Apply for CDC RFA PS09 9020301SUPP11
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Comprehensive STD Prevention Systems Infertility Prevention Project" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.977 Preventive Health ServicesSexually Transmitted Diseases Control Grants.
- This funding opportunity was created on Jan 31, 2011 and posted on Jan 20, 2011.
- Applicants must submit their applications by Mar 21, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $730,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $51,648.00 in funding.
- The number of recipients for this funding is limited to 64 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants are the 64 official public health agencies that are current recipients of project grants for Preventative Health Services Sexually Transmitted Disease Control grants, IPP component (The Chicago project area does not receive IPP funds). These applicants have the necessary infrastructure in place to perform the activities required and have the experience needed to successfully complete the required functions.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Comprehensive STD Prevention Systems Infertility Prevention Project supplement (Funding Opportunity Number CDC RFA PS09-90203-01SUPP11) is a CDC discretionary funding opportunity offered as a cooperative agreement to strengthen and expand existing sexually transmitted disease (STD) prevention capacity, with a specific emphasis on increasing chlamydia and gonorrhea (CT/GC) screening and treatment services. The central purpose of the supplement is to provide additional resources to established project-area STD prevention programs so they can scale targeted testing and ensure timely, appropriate treatment, which is a critical public health strategy for reducing transmission, preventing reinfection, and limiting serious downstream health outcomes such as pelvic inflammatory disease and infertility.
A key expectation of the opportunity is that proposed CT/GC screening and treatment activities are not one-size-fits-all, but instead are driven by local epidemiology. Applicants are expected to base their plans on program decisions informed by local disease trends, surveillance data, and disease prevalence estimates. In practical terms, this means jurisdictions should use their existing public health data and program experience to determine which populations, settings, and geographic areas to prioritize for expanded screening and treatment, aiming to concentrate efforts where burden and risk are highest and where added investment is likely to produce measurable impact.
Eligibility is limited and highly targeted. Only the 64 official public health agencies that were current recipients of Preventive Health Services Sexually Transmitted Disease Control Grants (CFDA 93.977), specifically the Infertility Prevention Project (IPP) component, were eligible to apply. The rationale is that these agencies already have the infrastructure, staffing, partnerships, and operational experience needed to implement expanded screening and treatment quickly and effectively. The listing notes that the Chicago project area does not receive IPP funds, indicating a notable exception within the otherwise defined eligible pool.
From a funding standpoint, the CDC anticipated making up to 64 awards, aligning with the number of eligible project areas. The estimated total funding available was $730,000, with individual award amounts ranging from an award floor of $277 to an award ceiling of $51,648. There was no cost sharing or matching requirement, which lowers barriers for public health agencies and signals that the CDC intended the supplement to function as additive support to ongoing program operations rather than requiring new non-federal commitments.
Important administrative details include the posting date of January 20, 2011, and a creation date of January 31, 2011. The original application deadline was February 22, 2011, later extended to a current closing date of March 21, 2011, with an archive date of April 20, 2011. The funding activity category is Health, and the instrument type being a cooperative agreement indicates that CDC involvement was expected beyond simply issuing funds, typically through substantial programmatic collaboration, guidance, and monitoring consistent with cooperative agreement structures.
For applicants needing assistance accessing the full announcement, the contact listed is the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700. The opportunity text indicates that the "Additional Information" link was not active in the listing and directs users to access the Full Announcement through the posting interface, suggesting that full requirements, submission instructions, and any specific reporting or performance expectations were detailed in that complete announcement.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
This opportunity is the Comprehensive STD Prevention Systems Infertility Prevention Project supplement, identified as Funding Opportunity Number (FON) CDC RFA PS09-90203-01SUPP11.
Who is offering this funding?
The funding is offered by the Centers for Disease Control and Prevention (CDC) as a discretionary funding opportunity.
What type of funding mechanism is this?
The instrument type is a cooperative agreement, which generally means CDC involvement is expected beyond issuing funds, typically through programmatic collaboration, guidance, and monitoring consistent with cooperative agreement structures.
What is the main purpose of this supplement?
The central purpose is to provide additional resources to established project-area STD prevention programs so they can strengthen and expand existing STD prevention capacity, with a specific emphasis on increasing chlamydia and gonorrhea (CT/GC) screening and treatment services.
What public health outcomes is the supplement trying to impact?
The supplement is positioned as a strategy to reduce transmission, prevent reinfection, and limit serious downstream health outcomes such as pelvic inflammatory disease and infertility by supporting timely, appropriate treatment alongside expanded screening.
Which diseases and services are specifically emphasized?
The specific emphasis is on chlamydia and gonorrhea (CT/GC) screening and treatment services, including scaling targeted testing and ensuring timely, appropriate treatment.
Does the opportunity expect jurisdictions to use local data to shape activities?
Yes. Applicants are expected to propose screening and treatment activities driven by local epidemiology, using local disease trends, surveillance data, and disease prevalence estimates to decide which populations, settings, and geographic areas to prioritize.
Is a one-size-fits-all approach to screening and treatment acceptable under this opportunity?
No. The opportunity explicitly indicates that proposed CT/GC screening and treatment activities are not intended to be one-size-fits-all and should instead be informed by local epidemiology and program experience.
Who is eligible to apply?
Eligibility is limited to the 64 official public health agencies that were current recipients of Preventive Health Services Sexually Transmitted Disease Control Grants (CFDA 93.977), specifically the Infertility Prevention Project (IPP) component.
Why is eligibility limited to current IPP recipients?
The stated rationale is that these agencies already have the infrastructure, staffing, partnerships, and operational experience needed to implement expanded screening and treatment quickly and effectively.
Are there any notable exceptions mentioned within the eligible pool?
Yes. The listing notes that the Chicago project area does not receive IPP funds, which is highlighted as a notable exception within the otherwise defined eligible pool.
How many awards did CDC anticipate making?
CDC anticipated making up to 64 awards, aligning with the number of eligible project areas.
What is the estimated total funding available?
The estimated total funding available was $730,000.
What is the expected size of individual awards?
Individual award amounts ranged from an award floor of $277 to an award ceiling of $51,648.
Is there a cost sharing or matching requirement?
No. The opportunity states there is no cost sharing or matching requirement.
When was this opportunity posted?
The posting date is January 20, 2011.
What is the creation date listed for the opportunity?
The creation date is January 31, 2011.
What was the original application deadline?
The original application deadline was February 22, 2011.
Was the deadline extended?
Yes. The deadline was extended to a current closing date of March 21, 2011.
When was the opportunity archived?
The archive date is April 20, 2011.
What is the funding activity category?
The funding activity category is Health.
Where should applicants look for full requirements and instructions?
The listing indicates that the "Additional Information" link was not active and directs users to access the Full Announcement through the posting interface, where full requirements, submission instructions, and any specific reporting or performance expectations were expected to be detailed.
Who can be contacted for technical help accessing the full announcement?
The contact listed is the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS). They can be reached by phone at 770-488-2700.
What does the supplement expect programs to do differently with the added resources?
Based on the description, programs are expected to scale targeted testing and ensure timely, appropriate treatment for CT/GC, focusing efforts where burden and risk are highest and where added investment is likely to produce measurable impact.
Browse more opportunities from the same category: Health
Next opportunity: Supporting the Ghana AIDS Commission (GAC) for Coordination of the Multi Sectoral Response to HIV/AIDS in Ghana under the President s Emergency Plan for AIDS Relief
Previous opportunity: Partnering with the National Institute of Hygiene and Epidemiology to Enhance Disease Surveillance and National Laboratory Capacity for HIV Activities in Vietnam under the President s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS09 9020301SUPP11
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS09 9020301SUPP11) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting the Ghana AIDS Commission (GAC) for Coordination of the Multi Sectoral Response to HIV/AIDS in Ghana under the President s Emergency Plan for AIDS Relief Apply for CDC RFA GH11 1131 Funding Number: CDC RFA GH11 1131 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the Malawi National AIDS Commission in the Coordination of National HIV Policy, Strategic Information and Capacity Building Activities in the Republic of Malawi under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1133 Funding Number: CDC RFA GH11 1133 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the Safe, Adequate and Reliable Supply of Blood and Blood Products through the Malawi Blood Transfusion Service and its Support to Hospitals throughout Malawi, under the PEPFAR and the Global Health Initiative Apply for CDC RFA GH11 1134 Funding Number: CDC RFA GH11 1134 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the Ministry of Public Health, Directorate of Family Health to Integrate Comprehensive Prevention of Mother to Child Transmission of HIV Activities into Maternal and Child Health Services in Cameroon under PEPFAR Apply for CDC RFA GH11 1156 Funding Number: CDC RFA GH11 1156 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $775,200 |
| NIDCD Community Wide Scientific Resources Limited Competition (R24) Apply for PAR 11 103 Funding Number: PAR 11 103 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the National Institutes of Health in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1158 Funding Number: CDC RFA GH11 1158 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Coordination Role of the Ministry Responsible for the Fight Against AIDS in Cote dIvoire under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1198 Funding Number: CDC RFA GH11 1198 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Botswana Civil Society Strengthening Program Apply for 674 11 0003 Funding Number: 674 11 0003 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $20,000,000 |
| Strategies to Increase Health Care Providers Use of Population Based Immunization Information Systems Apply for RFA IP 11 008 Funding Number: RFA IP 11 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Support to Local Indigenous Partners in the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Faith Based Affiliated Sites in the Republic of Guyana under the President s Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH11 1140 Funding Number: CDC RFA GH11 1140 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the National Tuberculosis Prevention Program to Conduct TB Prevention in Haiti under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1195 Funding Number: CDC RFA GH11 1195 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Health Impact Assessment to Foster Healthy Community Design Apply for CDC RFA EH11 1104 Funding Number: CDC RFA EH11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $180,000 |
| Nurse Faculty Loan Program Apply for HRSA 11 045 Funding Number: HRSA 11 045 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Scholarships for Disadvantaged Students Apply for HRSA 11 074 Funding Number: HRSA 11 074 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ruth K. Kirchstein National Research Service Award (NRSA) Institutional Research Training Grant Apply for HRSA 11 054 Funding Number: HRSA 11 054 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Health Promotion and Disease Prevention Research Centers Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 09 001 Funding Number: RFA DP 09 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Healthy Homes and Lead Poisoning Prevention Program Apply for CDC RFA EH11 1102 Funding Number: CDC RFA EH11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 11 141 Funding Number: HRSA 11 141 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part D Coordinated HIV Services and Access to Research for Women, Infant, Children and Youth Apply for HRSA 11 093 Funding Number: HRSA 11 093 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Clinical Interventions to Increase Organ Procurement Apply for HRSA 11 025 Funding Number: HRSA 11 025 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS09 9020301SUPP11", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
